New Pharma Company Lands $354 Million Government Contract To Produce Coronavirus Drugs In The U.S.

  • 📰 Forbes
  • ⏱ Reading Time:
  • 13 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 8%
  • Publisher: 53%

Россия Новости Новости

Россия Последние новости,Россия Последние новости

Newly launched Phlow Corp. gets second government contract this month to manufacture drugs and active pharmaceutical ingredients in the states.

Monday evening the U.S. government signed a $354 million four-year contract with new pharmaceutical company Phlow Corporation to increase American production of medications that may help treat Covid-19 in a bid to avoid potential supply chain shortages, with the potential to extend the contract to $812 million for the next 10 years according to theThis is one of the largest-ever grants awarded by America’s Biomedical Advanced Research and Development Authority, also known as BARDA.

Most pharmaceutical companies make medication in batches, pausing for quality control measurements and transferring components of the medication to other machines or even other countries in order to finalize production of a medication.

 

Спасибо за ваш комментарий. Ваш комментарий будет опубликован после проверки

Huh. Well how about that.

Мы обобщили эту новость, чтобы вы могли ее быстро прочитать.Если новость вам интересна, вы можете прочитать полный текст здесь Прочитайте больше:

 /  🏆 394. in RU

Россия Последние новости, Россия Последние новости

Similar News:Вы также можете прочитать подобные новости, которые мы собрали из других источников новостей

Trump's New COVID-19 Czar Holds $10 Million In Stock Options In Vaccine CompanySen. Elizabeth Warren slams 'huge conflict of interest,' and demands Moncef Slaoui 'divest immediately.'
Источник: HuffPostWomen - 🏆 27. / 68 Прочитайте больше »